Volume | 5,124 |
|
|||||
News | - | ||||||
Day High | 4.6892 | Low High |
|||||
Day Low | 4.42 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Helius Medical Technologies Inc | HSDT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.43 | 4.42 | 4.6892 | 4.50 | 4.44 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
80 | 5,124 | $ 4.53 | $ 23,221 | - | 4.29 - 14.44 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:12:06 | 5 | $ 4.69 | USD |
Helius Medical Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.19M | 708.25k | - | 644k | -8.85M | -12.50 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Helius Medical Technolog... News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HSDT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 5.00 | 5.19 | 4.42 | 4.81 | 9,314 | -0.50 | -10.00% |
1 Month | 5.60 | 7.188 | 4.42 | 6.42 | 333,879 | -1.10 | -19.64% |
3 Months | 6.97 | 9.50 | 4.29 | 6.20 | 439,388 | -2.47 | -35.44% |
6 Months | 7.34 | 9.50 | 4.29 | 6.23 | 207,877 | -2.84 | -38.69% |
1 Year | 9.875 | 14.44 | 4.29 | 8.29 | 368,867 | -5.38 | -54.43% |
3 Years | 867.50 | 881.50 | 4.29 | 39.49 | 689,327 | -863.00 | -99.48% |
5 Years | 4,025.00 | 5,792.50 | 4.29 | 333.51 | 558,976 | -4,020.50 | -99.89% |
Helius Medical Technolog... Description
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise. The company derives its revenue from Product Sales, fees and; license sources. |